Ignite Creation Date:
2025-12-26 @ 1:18 PM
Ignite Modification Date:
2025-12-31 @ 1:10 PM
Study NCT ID:
NCT06729606
Status:
COMPLETED
Last Update Posted:
2025-10-09
First Post:
2024-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-20
Completion Date Type:
ACTUAL
First Submit Date:
2024-12-10
First Submit QC Date:
None
Study First Post Date:
2024-12-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-05-29
Results First Submit QC Date:
None
Results First Post Date:
2025-10-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-23
Last Update Post Date:
2025-10-09
Last Update Post Date Type:
ESTIMATED